drugset / Trial / NCT00835419
Efficacy Study Of P276-00 In Subjects Of Malignant Melanoma Positive For Cyclin D1 Expression
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate efficacy of P276-00 in subjects with advanced malignant melanoma positive for cyclin D1 expression
Timeline
- Start
- 2009-05
- Primary completion
- 2011-04
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | P276-00 | Small molecule | — | — |